SEARCH
検索詳細
小野 竜輔大学院医学研究科 医科学専攻准教授
研究活動情報
■ 論文- Elsevier BV, 2024年02月, Journal of Dermatological Science研究論文(学術雑誌)
- INTRODUCTION: Xeroderma pigmentosum (XP) is a rare intractable disease without a fundamental treatment, presenting with severe photosensitivity, freckle-like pigmented and depigmented maculae and numerous skin cancers before the age of 10 years without strict sun protection. About 70% of the patients exhibit extremely severe sunburn reactions and most of them develop neurological symptoms, including sensorineural hearing impairment and progressive peripheral and central nervous disorders beginning from childhood ages. In the preclinical study, we found that N-acetyl-5-methoxytryptamine was effective in suppressing skin tumour development in addition to improvement of auditory brainstem response in chronically ultraviolet-irradiated XP-A model mice. METHODS AND ANALYSIS: On the bases of the preclinical study, we conduct a clinical trial on the efficacy of NPC-15 for patients with XP with exaggerated sunburn reaction type by a multicentre, double-blinded placebo-controlled, two-group crossover study followed by a 52 weeks open study. ETHICS AND DISSEMINATION: Ethics approval is overseen by the Kobe University Institutional Review Board and Osaka Medical and Pharmaceutical University Institutional Review Board, and the study is conducted in accordance with the approved protocol. All participants will be required to provide written informed consent. Findings will be disseminated through scientific and professional conferences and peer-reviewed journal publications. The data sets generated during the study will be available from the corresponding author on reasonable request. TRIAL REGISTRATION NUMBER: jRCTs051210181.2023年03月, BMJ open, 13(3) (3), e068112, 英語, 国際誌研究論文(学術雑誌)
- Omalizumab is known to be effective in treating chronic spontaneous urticaria (CSU) with an inadequate response to H1 -antihistamine. Although many reports have described pre-treatment biomarkers to predict the efficacy of omalizumab in CSU, there are few reports that examined the relationship between age and the therapeutic effectiveness of omalizumab. Thus, we aimed to investigate the relationship between response to omalizumab and age. This retrospective study comprised 52 CSU patients receiving three consecutive omalizumab courses during the period from April 2017 to March 2021. Participants were categorized as responders or non/partial responders using the urticaria control test to evaluate clinical variables on week 12. The female rate tended to be higher, and the mean age and the median disease duration tended to be lower with no significance in responders compared with in non/partial responders. In addition, they exhibited no significant differences regarding serum immunoglobulin E levels, basophil counts, eosinophil counts, d-dimer, and autologous serum skin test results reported as predictor in the past between two groups. Interestingly, when patients were categorized as age <65 years or ≥65 years, those in the ≥65 years group had a significantly lower response to omalizumab than those aged <65 years. These findings suggest that physicians should keep in mind that the age of their CSU patients may be a predictor of the therapeutic efficacy of omalizumab.2022年03月, The Journal of dermatology, 49(7) (7), 729 - 731, 英語, 国際誌研究論文(学術雑誌)
- BACKGROUND: Xeroderma pigmentosum (XP) is hereditary disorder characterized by photosensitivity, predisposition to skin cancers of sun-exposed body sites and progressive neurologic symptoms in some cases. Cells from XP patients show higher sensitivity to ultraviolet radiation (UV) than normal cells. OBJECTIVE: We aimed to ascertain the genes differentially regulated in XP complementation group A (XP-A) cells after UV irradiation. METHODS: XP-A cells were harvested at 4 or 12 h after a single exposure to low-dose UV-C radiation and subjected to transcriptome analysis by microarray. RESULTS: The number of genes with significantly altered expression (≥2-fold difference) at 12 h was markedly higher in XP-A cells than that in normal cells, suggesting that the number of altered genes could be correlated to the amount of DNA damage. CONCLUSION: We recently reported that mitotic genes are induced in normal human fibroblasts after UV-C exposure, and similar results were observed in XP-A cells as normal cells. In addition, a majority of replication-related genes were significantly upregulated in XP-A cells, whereas no such expression pattern was observed in the normal control cells. Collectively, these results indicate that the XPA protein can transcriptionally inhibit the series of replication-related genes, and could possibly regulate replication and/or re-replication after UV irradiation.2022年03月, Journal of dermatological science, 105(3) (3), 152 - 158, 英語, 国際誌研究論文(学術雑誌)
- (一社)日本皮膚悪性腫瘍学会, 2021年06月, 日本皮膚悪性腫瘍学会学術大会プログラム・抄録集, 37回, 146 - 146, 日本語悪性黒色腫肺転移に対してnivolumabにて加療した色素性乾皮症バリアント型の1例
- (公社)日本皮膚科学会, 2021年05月, 日本皮膚科学会雑誌, 131(5) (5), 1386 - 1386, 日本語慢性蕁麻疹に対するオマリズマブの治療反応性予測因子と長期的使用実態に関する後方視的解析
- 2021年02月, The Journal of dermatology, 48(2) (2), e94-e95, 英語, 国際誌
- A case of xeroderma pigmentosum (XP) group D in a 39-year-old Japanese man is reported. The patient had suffered from moderate to severe solar sensitivity and freckle-like pigmented macules in sun-exposed areas since 6 years of age, and developed skin malignancies such as squamous cell carcinoma, actinic keratosis, Bowen's disease and basal cell carcinoma. The minimal erythema dose for ultraviolet (UV) radiation was decreased with a delayed peak reaction. The level of unscheduled DNA synthesis of fibroblasts from the patient was 70% of normal, while they expressed POLH, a gene product responsible for the XP variant. Whole-exome sequencing indicated that the patient harbored a homozygous mutation of c.1802G>T, p.Arg601Leu in ERCC2. A genetic complementation test was carried out by host cell reactivation assay, which showed that the patient's fibroblasts recovered only when they were transfected with XPD cDNA, confirming the diagnosis of XP-D. Arg601Leu mutation in ERCC2 may be related to mild UV radiation sensitivity and moderate skin lesions.2021年01月, The Journal of dermatology, 48(1) (1), 96 - 100, 英語, 国際誌研究論文(学術雑誌)
- (株)医学書院, 2020年05月, 臨床皮膚科, 74(6) (6), 423 - 429, 日本語
- 日本皮膚科学会-大阪地方会・京滋地方会, 2019年02月, 皮膚の科学, 18(1) (1), 53 - 53, 日本語51歳で診断されたXP-G群の1例[査読有り]
- 2019年01月, 皮膚病診療, 41(1号) (1号), 57 - 60, 日本語【小児先天性皮膚疾患】臨床例 色素性乾皮症D群の小児[査読有り][招待有り]研究論文(学術雑誌)
- 日本皮膚科学会-大阪地方会・京滋地方会, 2018年12月, 皮膚の科学, 17(6) (6), 375 - 375, 日本語重症アトピー性皮膚炎としてフォローされていたFolliculotropic mycosis fungoidesの1例[査読有り]
- 2018年06月, BRITISH JOURNAL OF DERMATOLOGY, 178(6) (6), 1451 - +, 日本語研究論文(学術雑誌)
- 2018年02月, The Journal of investigative dermatology, 138(2) (2), 467 - 470, 英語, 国際誌研究論文(学術雑誌)
- 2017年02月, Journal of dermatological science, 85(2) (2), 140 - 143, 英語, 国際誌[査読有り]
- 2016年08月, EXPERIMENTAL DERMATOLOGY, 25, 28 - 33, 英語[査読有り]研究論文(学術雑誌)
- 2016年07月, SCIENTIFIC REPORTS, 6, 29233, 英語[査読有り]研究論文(学術雑誌)
- BACKGROUND: Most patients with xeroderma pigmentosum complementation group D (XP-D) from Western countries suffer from neurological symptoms, whereas Japanese patients display only skin manifestations without neurological symptoms. We have previously suggested that these differences in clinical manifestations in XP-D patients are attributed partly to a predominant mutation in ERCC2, and the allele frequency of S541R is highest in Japan. METHODS: We diagnosed a child with mild case of XP-D by the evaluation of DNA repair activity and whole-genome sequencing, and followed her ten years. RESULTS: Skin cancer, mental retardation, and neurological symptoms were not observed. Her minimal erythema dose was 41 mJ/cm(2) , which was slightly lower than that of healthy Japanese volunteers. The patient's cells showed sixfold hypersensitivity to UV in comparison with normal cells. Post-UV unscheduled DNA synthesis was 20.4%, and post-UV recovery of RNA synthesis was 58% of non-irradiated samples, which was lower than that of normal fibroblasts. Genome sequence analysis indicated that the patient harbored a compound heterozygous mutation of c.1621A>C and c.591_594del, resulting in p.S541R and p.Y197* in ERCC2: then, patient was diagnosed with XP-D. Y197* has not been described before. CONCLUSION: Her mild skin manifestations might be attributed to the mutational site on her genome and daily strict sun protection. c.1621A>C might be a founder mutation of ERCC2 among Japanese XP-D patients, as it was identified most frequently in Japanese XP-D patients and it has not been found elsewhere outside Japan.2016年07月, Photodermatology, photoimmunology & photomedicine, 32(4) (4), 174 - 80, 英語, 国際誌[査読有り]研究論文(学術雑誌)
- 2015年04月, 皮膚の科学, 14(2号) (2号), 89 - 90, 日本語免疫抑制剤の長期使用中に発生した皮膚悪性腫瘍の2例[査読有り]研究論文(学術雑誌)
- 2014年10月, JOURNAL OF INVESTIGATIVE DERMATOLOGY, 134(10) (10), 2610 - 2619, 英語[査読有り]研究論文(学術雑誌)
- 2014年06月, JOURNAL OF INVESTIGATIVE DERMATOLOGY, 134(6) (6), 1775 - 1778, 英語[査読有り]研究論文(学術雑誌)
- 2013年07月, Bioengineered, 4(4) (4), 254 - 257, 英語[査読有り]研究論文(学術雑誌)
- 2013年07月, BIOENGINEERED, 4(4) (4), 254 - 257, 英語[査読有り]研究論文(学術雑誌)
- 68歳,女性。約2ヵ月前より臍部の硬結を自覚した。皮膚生検の病理組織学的検討では角化傾向を有する異型性の強い腫瘍細胞が表皮と連続性に真皮深層まで浸潤する像がみられたことより皮膚有棘細胞癌と考えた。術前のMRI検査で,腹腔内膀胱上方に10.5×13.5×17cm大の表面平滑で周囲組織と境界明瞭な腫瘤がみられ,良性卵巣嚢腫が疑われた。しかし,臍部の腫瘤とともに行った嚢腫の摘出術で術中に悪性と診断,腸間膜を含め拡大切除した。最終的に,自験例は右卵巣成熟嚢胞奇形腫の悪性転化とそれに伴うSister Mary Joseph's Noduleと診断した。術後維持化学療法としてTC(Paclitaxel・Carboplatin)療法を施行し,約1年6ヵ月寛解を維持している。卵巣成熟嚢胞奇形腫は稀に悪性化し,その場合,扁平上皮癌の組織像を呈することが多い。臍部に転移すると皮膚有棘細胞癌と鑑別が困難となる。自験例は皮膚科医にとって重要な知見と考えられた。The Japanese Skin Cancer Society, 2013年06月, Skin Cancer, 28(1号) (1号), 34 - 38, 日本語[査読有り]研究論文(学術雑誌)
- 2013年06月, PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 29(3) (3), 132 - 139, 英語[査読有り]研究論文(学術雑誌)
- 2013年05月, Photochemistry and Photobiology, 89(3) (3), 649 - 654, 英語[査読有り]研究論文(学術雑誌)
- (公社)日本皮膚科学会, 2013年04月, 日本皮膚科学会雑誌, 123(4) (4), 494 - 494, 日本語腸上皮化生を認めたストマ周囲潰瘍の1例[査読有り]
- 2013年, FRONTIERS IN IMMUNOLOGY, 4, 英語[査読有り]研究論文(学術雑誌)
- 2012年12月, JOURNAL OF DERMATOLOGY, 39(12) (12), 1041 - 1043, 英語[査読有り]研究論文(学術雑誌)
- 2012年12月, Derma., (199号) (199号), 1 - 6, 日本語【顔面の腫瘤 鑑別診断と治療】 色素性乾皮症に合併する顔面の皮膚腫瘍[査読有り]研究論文(学術雑誌)
- Different wavelengths of ultraviolet (UV) light have different promoting effects on skin carcinogenesis. Narrowband UVB (NB-UVB) has a single-peak wavelength of 311 nm and is widely used for treating skin diseases. Our previous work showed that, in comparison with conventional broadband UVB (BB-UVB), long-term exposure to NB-UVB induces higher frequency of skin cancer in mice, and it suggested that this is mediated through the formation of cyclobutane pyrimidine dimers (CPDs). To explore whether the frequency of p53 mutations in skin tumours correlates with CPD-induced mutations, we compared the frequency and types of p53 mutations between NB-UVB-induced and BB-UVB-induced malignant skin tumours produced in wild-type and Ogg1 knockout mice, which are deficient in repair of oxidative 8-oxoguanine (8-oxoG), a DNA damage mediated by reactive oxygen species (ROS). The frequency of p53 mutation was significantly higher in NB-UVB-induced than in BB-UVB-induced tumours in both wild-type and Ogg1 knockout mice. Most of the p53 mutations found were G:C → A:T transitions at dipyrimidine sites in both the NB-UVB- and BB-UVB-exposed groups. However, G:C → T:A mutations caused by 8-oxoG did not increase in Ogg1 knockout mice exposed to either NB-UVB or BB-UVB. Our results strongly suggest that NB-UVB induces highly malignant tumours caused by p53 dipyrimidine mutations through the formation of CPDs.2012年11月, Mutagenesis, 27(6) (6), 637 - 643, 英語, 国際誌[査読有り]研究論文(学術雑誌)
- 2012年10月, JOURNAL OF DERMATOLOGY, 39(10) (10), 843 - 851, 英語[査読有り]研究論文(学術雑誌)
- 2012年09月, 診療と新薬, 49(9号) (9号), 1131 - 1137, 日本語レボセチリジン塩酸塩の皮脂欠乏性皮膚炎に対する有用性の検討[査読有り]研究論文(学術雑誌)
- 2011年04月, Skin Research, 10(2) (2), 133 - 140, 日本語Six cases of photosensitive disorders probably due to hydrochlorothiazide研究論文(学術雑誌)
- 2009年10月, J Invest Dermatol, 130(5) (5), 1428 - 1437, 英語[査読有り]研究論文(学術雑誌)
- 2008年11月, Journal of dermatological science, 52(2) (2), 144 - 8, 英語
- 医学書院, 2008年05月, 臨床皮膚科, 62(6号) (6号), 390 - 393, 日本語重複癌に合併した線状IgA水疱性皮膚症[査読有り]研究論文(学術雑誌)
- 2005年10月, 皮膚病診療, 27(10号) (10号), 1185 - 1188, 日本語【薬疹-2005】 臨床例 メシル酸イマチニブによる扁平苔癬型薬疹[査読有り]研究論文(学術雑誌)
- 医学書院, 2003年05月, 臨床皮膚科, 57(6号) (6号), 473 - 475, 日本語重症皮膚石灰沈着症を伴ったoverlap症候群の1例[査読有り]研究論文(学術雑誌)
- (一社)日本皮膚悪性腫瘍学会, 2020年12月, 日本皮膚悪性腫瘍学会学術大会プログラム・抄録集, 36回, 161 - 161, 日本語当施設にてSPECT/CTを利用したRI法によりセンチネルリンパ節生検を検討した皮膚悪性腫瘍72症例のまとめ
- 日本皮膚科学会-大阪地方会・京滋地方会, 2020年12月, 皮膚の科学, 19(4) (4), 269 - 270, 日本語尋常性天疱瘡の治療中に足趾に生じた増殖性天疱瘡の1例
- (公社)日本皮膚科学会, 2020年05月, 日本皮膚科学会雑誌, 130(5) (5), 1235 - 1235, 日本語巨大な有棘細胞癌を形成したXP-C群の1例
- Xeroderma pigmentosum (XP) is a rare autosomal recessive hereditary disease caused by deficiency in repair of DNA lesions generated by ultraviolet radiation and other compounds. Patients with XP display pigmentary change and numerous skin cancers in sun-exposed sites, and some patients show exaggerated severe sunburns even upon minimum sun exposure as well as neurological symptoms. We conducted a nationwide survey for XP since 1980. In Japan, the frequency of the XP complementation group A is the highest, followed by the variant type; while in the Western countries, those of groups C or D are the highest. Regarding skin cancers in XP, basal cell carcinoma was the most frequent cancer that afflicted patients with XP, followed by squamous cell carcinoma, and malignant melanoma. The frequency of these skin cancers in patients with XP has decreased in these 20 years, and the age of onset of developing skin cancers is higher than those previously observed, owing to early diagnosis and education to patients and care takers on strict prevention from sunlight for patients with XP. On the other hand, the effective therapy for neurological XP has not been established yet, and this needs to be done urgently.2019年01月, Photochem Photobiol, 95(1) (1), 140 - 153, 英語, 国際誌[査読有り]記事・総説・解説・論説等(学術雑誌)
- 2017年05月, JOURNAL OF INVESTIGATIVE DERMATOLOGY, 137(5) (5), S131 - S131, 英語Truncated XPA protein could not interact with TFIIH but presented mild clinical manifestations研究発表ペーパー・要旨(国際会議)
- 2014年10月, JOURNAL OF DERMATOLOGY, 41, 14 - 14, 英語GENOTYPE -PHENOTYPE CORRELATION AMONG XERODERMA PIGMENTOSUM COMPLEMENTATION GROUP D研究発表ペーパー・要旨(国際会議)
- (一社)日本放射線影響学会, 2014年09月, 日本放射線影響学会大会講演要旨集, 57回, 143 - 143, 日本語低線量紫外線照射が遺伝子発現プロファイルに与える影響
- (一社)日本放射線影響学会, 2014年09月, 日本放射線影響学会大会講演要旨集, 57回, 144 - 144, 日本語A群色素性乾皮症患者細胞における低線量紫外線照射時の網羅的遺伝子発現解析
- 2014年03月, International Symposium on Xeroderma Pigmentosum and Related Disease, 英語Hearing loss in Xeroderma pigmnetosum and mechanism of inner ear disorder.研究発表ペーパー・要旨(全国大会,その他学術会議)
- 2013年05月, JOURNAL OF INVESTIGATIVE DERMATOLOGY, 133, S214 - S214, 英語The inhibitory effect of Spirulina platensis on UVB-induced skin carcinogenesis: Anti-inflammatory and antioxidant mechanisms研究発表ペーパー・要旨(国際会議)
- 2013年01月, Bioengineered, 4(4) (4), 1 - 4, 英語Suppressive effect of administration of human recombinant thioredoxin on ultrviolet light-induced inflammation and apoptosis of murine skin記事・総説・解説・論説等(その他)
- 2012年07月, BRITISH JOURNAL OF DERMATOLOGY, 167(1) (1), 204 - 206, 英語速報,短報,研究ノート等(学術雑誌)
- Excessive exposure to UV radiation is a major risk factor for developing skin cancer. UV-induced reactive oxygen species (ROS) cause accumulation of DNA damage products such as 8-oxoguanine (8-oxoG) in the skin. We have previously shown that mice lacking the repair enzyme 8-oxoguanine glycosylase (Ogg1 knockout mice) are highly susceptible to skin cancer after long-term UVB exposure. To investigate the genes involved, we performed gene profiling of Ogg1 knockout mouse skin after UVB exposure. Among the up-regulated genes in UVB-treated Ogg1 knockout mice, inflammatory response pathway-related genes were most affected. The Vcan gene, which encodes the large extracellular matrix proteoglycan versican, was continuously up-regulated in UVB-treated Ogg1 knockout mice, suggesting that versican is a mediator of skin cancer development. We examined the expression pattern of versican in skin tumors from wild-type mice and UVB-treated Ogg1 knockout mice, and also analyzed 157 sun-related human skin tumors. Versican was strongly expressed in malignant skin tumors in both mice and humans, and especially in Ogg1 knockout mice. Additionally, infiltrating neutrophils strongly colocalized with versican in UVB-treated Ogg1 knockout mouse skin. These data demonstrate that inflammatory responses, particularly neutrophil infiltration and versican up-regulation, are closely involved in UVB/ROS-induced skin tumorigenesis.2011年12月, The American journal of pathology, 179(6) (6), 3056 - 65, 英語, 国際誌
- 2008年04月, JOURNAL OF INVESTIGATIVE DERMATOLOGY, 128, S123 - S123, 英語Founder mutations in the DNA polymerase eta gene in Japanese patients diagnosed as xeroderma pigmentosum variant type研究発表ペーパー・要旨(国際会議)
- 2007年07月, JOURNAL OF INVESTIGATIVE DERMATOLOGY, 127(7) (7), 1745 - 1751, 英語記事・総説・解説・論説等(学術雑誌)
- 医学書院, 2004年10月, 臨床皮膚科, 58(11) (11), 920 - 923, 日本語症例報告 アニサキスによる蕁麻疹を合併し,自己血清皮内反応陽性を示したアスピリン不耐症の1例
■ 講演・口頭発表等
- 第471回日本皮膚科学会大阪地方会, 2019年02月, 日本語, 大阪, 国内会議創内持続陰圧洗浄療法により治療したフルニエ壊疽の1例口頭発表(一般)
- 第10回レックリングハウゼン病学会学術大会, 2019年02月, 日本語, 名古屋, 国内会議びまん性神経線維腫症に動脈塞栓療法を併用して治療したNF1の1例口頭発表(一般)
- 第471回日本皮膚科学会大阪地方会, 2019年02月, 日本語, 大阪, 国内会議51歳で診断されたXP-G群の1例口頭発表(一般)
- 第470回 日本皮膚科学会 大阪地方会, 2018年12月, 日本語, 大阪, 国内会議重症アトピー性皮膚炎としてフォローされていたFolliculotropic mycosis fungoidesの1例口頭発表(一般)
- 第40回日本光医学・光生物学会, 2018年07月, 日本語, 仙台, 国内会議神経症状を合併した色素性乾皮症D群の2例口頭発表(一般)
- 第42回日本小児皮膚科学会学術大会, 2018年07月, 日本語, 東京, 国内会議色素性乾皮症D群の小児の1例口頭発表(一般)
- 第111回近畿集談会 第468回大阪地方会・第456回京滋地方会, 2018年07月, 日本語, 京都, 国内会議ペムブロリズマブ投与後に苔癬様反応を示す異なった形態の皮疹をきたした1例口頭発表(一般)
- 第120回兵庫県皮膚科医会, 2018年06月, 日本語, 神戸, 国内会議ペムブロリズマブ投与後に苔癬様反応を示す異なった形態の皮疹をきたした1例口頭発表(一般)
- 第467回日本皮膚科学会大阪地方会, 2018年05月, 日本語, 大阪, 国内会議結節性紅斑を合併した肉芽腫性乳腺炎の1例口頭発表(一般)
- 国際シンポジウム『早老症と関連疾患2018』(International Meeting on RECQ Helicases and Related Diseases 2018), 2018年02月, 英語, 難病医学研究財団, 千葉, 国際会議The present status of Xeroderma pigmentosum in Japan-evaluation of symptoms by severity scale score.[招待有り]シンポジウム・ワークショップパネル(指名)
- 日本研究皮膚科学会第42回年次学術大会・総会, 2017年12月, 英語, 日本研究皮膚科学会, 高知, 国内会議Replication-related genes are upregulated in XP-A cells after UV-C irradiation.口頭発表(一般)
- 2017 SID Annual Meeting, 2017年04月, 英語, Society for Investigative Dermatology, Portland, OR, USA, 国際会議Truncated XPA protein could not interact with TFIIH but presented mild clinical manifestations.ポスター発表
- 日本研究皮膚科学会第40回年次学術大会・総会, 2015年12月, 英語, 日本研究皮膚科学会, 岡山, 国内会議Usefulness of flow-cytometry based nucleotide excision repair assay for diagnosis of xeroderma pigmentosum variant type口頭発表(一般)
- 第39回日本小児皮膚科学会学術大会, 2015年07月, 日本語, 日本小児皮膚科学会, 鹿児島, 国内会議異常な日光皮膚炎症状を伴わない小児の色素性乾皮症の2例口頭発表(一般)
- 15th International Congress of Radiation Research, 2015年05月, 英語, International Congress of Radiation Research, Kyoto, 国際会議Transcriptome analysis with microarray in the human fibroblast exposed by low dose of UVポスター発表
- 第447回日本皮膚科学会大阪地方会, 2015年02月, 日本語, 日本皮膚科学大阪地方会, 大阪, 国内会議生体腎移植後の免疫抑制剤長期内服中に発症した露光部皮膚悪性腫瘍の2例口頭発表(一般)
- 日本研究皮膚科学会 第39回年次学術大会・総会, 2014年12月, 英語, 日本研究皮膚科学会, 大阪, 国内会議NER assay based on flow cytometery of pyrimidine dimerimmunocytochemistry: comparison with unscheduled DNA synthesis using autoradiography口頭発表(一般)
- 第44回日本皮膚アレルギー・接触皮膚炎学会総会学術大会, 2014年11月, 日本語, 日本皮膚アレルギー・接触皮膚炎学会, 仙台, 国内会議当科で経験した日光蕁麻疹22例の検討口頭発表(一般)
- 第57回日本放射線影響学会, 2014年10月, 日本語, 日本放射線影響学会, 鹿児島, 国内会議低線量紫外線照射が遺伝子発現プロファイルに与える影響口頭発表(一般)
- 第57回日本放射線影響学会, 2014年10月, 日本語, 日本放射線影響学会, 鹿児島, 国内会議A群色素性乾皮症患者細胞における低線量紫外線照射時の網羅的遺伝子発現解析口頭発表(一般)
- 3rd Eastern Asia Dermatology Congress, 2014年09月, 英語, Eastern Asia Dermatology Congress, Jeju, Korea, 韓国, 国際会議Genotype -Phenotype Correlation Among Xeroderma Pigmentosum Complementation Group D.シンポジウム・ワークショップパネル(公募)
- International Symposium on Xeroderma Pigmentosum and Related Diseases, 2014年03月, 英語, Kobe, Japan, 国際会議Molecular analysis of DNA repair defects in cells from Japanese patients with xeroderma pigmentosum Group Dポスター発表
- 厚生労働省科学研究費「神経皮膚症候群に関する調査研究班」平成25年度総会, 2013年12月, 日本語, 神経皮膚症候群に関する調査研究班, 東京, 国内会議DNA修復異常を伴う光線過敏症患者の分子細胞生物学的解析その他
- UV-ABClub 39, 2010年03月, 日本語, UV-ABClub, 京都, 国内会議塩酸ジブカイン含有OTC外用薬による接触皮膚炎の2例口頭発表(一般)
- 日本皮膚科学会第415回大阪地方会, 2009年10月, 日本語, 大阪地方会, 大阪, 国内会議妊娠にて増悪した連圏状粃糠疹の1例口頭発表(一般)
- 第31回日本光医学・光生物学会, 2009年07月, 日本語, 日本光医学・光生物学会, 大阪, 国内会議色素性乾皮症バリアント群の小児の2例口頭発表(一般)
- The 4th Joint Meeting of JDA and ACD, 2009年07月, 英語, Japanese Dermatological Association, Australasian College of Dermatologists, 札幌, 国際会議Photoallergic contact dermatitis due to OTC topical medicament containing dibcaine hydrochloride.シンポジウム・ワークショップパネル(公募)
- 第85回兵庫県皮膚科医会総会・学術集談会, 2009年06月, 日本語, 兵庫県皮膚科医会, 神戸, 国内会議ジブカイン含有OTC皮膚外用薬による光接触性皮膚炎口頭発表(一般)
- UV-ABClub 38, 2009年02月, 日本語, UV-ABClub, 名古屋, 国内会議神経症状を伴わない色素性乾皮症D群の5例口頭発表(一般)
- 第30回日本光医学・光生物学会, 2008年07月, 日本語, 日本光医学・光生物学会, 松江, 国内会議日本人色素性乾皮症バリアント群における遺伝子変異口頭発表(招待・特別)
- International Investigative Dermatology 2008, 2008年05月, 英語, IID, 京都, 国際会議Founder mutations in the DNA polymerase eta gene in Japanese patients diagnosed as xeroderma pigmentosum variant type.ポスター発表
- UV-ABClub37, 2008年03月, 日本語, UV-ABClub, 大阪, 国内会議色素性乾皮症C群の小児例口頭発表(一般)
- 第405回日本皮膚科学会大阪地方会, 2008年02月, 日本語, 日本皮膚科学会大阪地方会, 大阪, 国内会議色素性乾皮症C群の小児例口頭発表(一般)